Research entities
Compound Directory
An alphabetical directory of published research compounds, scientific aliases, development codes, and verified identifiers.
52 records
Linear melanocortin analogs
Melanotan I (Afamelanotide)
Melanotan I · Melanotan-1 · MT-I · MT-1 · NDP-MSH · NDP-alpha-MSH · CUV1647 · MBJ05
Afamelanotide, widely supplied as Melanotan I, is a linear thirteen-residue analog of alpha-melanocyte-stimulating hormone carrying norleucine and D-phenylalanine substitutions.
Melanocortin receptor ligands
alpha-MSH
α-MSH · alpha-MSH · alpha-melanotropin · Melanotropin alpha
alpha-MSH is the endogenous thirteen-residue melanocortin peptide hormone from which several of the synthetic compounds in this library are derived.
Amylin and calcitonin receptor agonists
Amylin (human IAPP)
Human islet amyloid polypeptide · IAPP · hIAPP · Amlintide
Amylin is the endogenous 37-residue human pancreatic peptide hormone, co-secreted with insulin, from which pramlintide and cagrilintide are both derived.
Growth hormone secretagogues
Anamorelin
ONO-7643 · RC-1291 · ST-1291
Anamorelin is a nonpeptide small-molecule agonist at the ghrelin receptor, structurally unrelated to the peptide secretagogues that share its target.
Regenerative peptides
BPC-157
Bepecin · BPC 15
BPC-157 is a synthetic fifteen-residue peptide corresponding to a partial sequence of body protection compound, a protein reported to have been isolated from human gastric juice.
Cyclic melanocortin analogs
PT-141 (Bremelanotide)
Bremelanotide · PT 141 · PT-141 free base · PT-141
PT-141, canonically bremelanotide, is a synthetic cyclic heptapeptide melanocortin receptor agonist, structurally the C-terminal free acid of the Melanotan II lactam scaffold.
Amylin and calcitonin receptor agonists
Cagrilintide
AM833 · AM-833 · NNC0174-0833
Cagrilintide is a long-acting synthetic amylin analog, lipidated and disulfide-cyclized, characterised at the calcitonin receptor and at amylin receptor complexes.
ARA-290
ARA 290 · Cibinetida · Cibinetidum · PHBSP
Cibinetide is a synthetic peptide corresponding to a surface region of erythropoietin, characterized in the literature as a selective agonist at a heteromeric receptor complex distinct from the erythropoietin receptor homodimer.
GHRH analogs
CJC-1295
CJC 1295
CJC-1295 designates a tetrasubstituted analog of human growth hormone-releasing factor residues 1 to 29, reported to act at the GRF receptor on the anterior pituitary.
Melanocortin fragment peptides · Melanocortin receptor ligands
Cosyntropin (ACTH 1-24)
Tetracosactide · ACTH(1-24) · alpha 1-24 corticotropin
Cosyntropin is the synthetic 1-24 fragment of adrenocorticotropic hormone, the melanocortin ligand of the MC2R branch.
DSIP
DSIP · Delta-sleep-inducing peptide
DSIP is a synthetic nonapeptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, first isolated and sequenced in 1978.
Epitalon
Epithalon · Epithalone · AEDG peptide
Epitalon is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, described in the source literature as a short peptide designed following work on pineal tissue extracts.
Growth hormone secretagogues
Examorelin (Hexarelin)
Hexarelin · EP-23905 · MF-6003
Examorelin, widely supplied as hexarelin, is a synthetic hexapeptide growth hormone secretagogue carrying a 2-methylated D-tryptophan.
GLP-1 receptor peptide analogs
Exenatide
Exendin-4
Exenatide is a 39-residue peptide with an N-terminal histidine and a C-terminal serine amide, originally isolated from Heloderma suspectum venom and characterized as a member of the glucagon superfamily.
Growth hormone secretagogues
Human Octanoyl-Ghrelin
Lenomorelin · Human acyl-ghrelin · Acyl-ghrelin
Human octanoyl-ghrelin is the endogenous 28-residue acylated peptide ligand of the ghrelin receptor, carrying an n-octanoyl ester on serine 3.
Growth hormone secretagogues
GHRP-6
Hexapeptide-2 · Growth hormone-releasing peptide-6
GHRP-6 is a synthetic hexapeptide with a C-terminal amide, characterized as an agonist at the growth hormone secretagogue receptor.
Incretin and glucagon receptor ligands
Glucagon
Glucagon(1-29)
Glucagon is the endogenous 29-residue pancreatic hormone and the native ligand of the glucagon receptor.
Incretin and glucagon receptor ligands
GLP-1(7-36) amide
GLP-1(7-36)amide · GLP-1 7-36 amide · Insulinotropin
GLP-1(7-36) amide is an endogenous processing form of glucagon-like peptide-1 and the native ligand against which the GLP-1 receptor agonists in this library are compared.
Incretin and glucagon receptor ligands
GLP-1(7-37)
GLP-1 7-37 · GLP-I(7-37)
GLP-1(7-37) is an endogenous processing form of glucagon-like peptide-1 retaining a C-terminal glycine, and the structural reference for several acylated GLP-1 analogs.
Incretin and glucagon receptor ligands
GIP(1-42)
GIP · Gastric inhibitory polypeptide · Glucose-dependent insulinotropic peptide
GIP is a 42-residue endogenous incretin hormone and the native ligand of the GIP receptor.
Thymosin-related peptides
Ac-SDKP (Goralatide)
Ac-SDKP · Seraspenide · N-acetyl-seryl-aspartyl-lysyl-proline
Ac-SDKP is the acetylated N-terminal tetrapeptide of thymosin beta-4, generated from the parent by sequential enzymatic processing.
Growth hormone secretagogues
Ipamorelin
NNC 26-0161
Ipamorelin is a synthetic pentapeptide with a C-terminal amide, characterized in its original report as a growth hormone secretagogue acting through a GHRP-like receptor rather than the GHRH receptor.
Kisspeptins
Kisspeptin-10
KP-10 · Metastin (45-54) · Human metastin 45-54
Kisspeptin-10 is the amidated ten-residue C-terminal fragment represented by the human KISS1-derived kisspeptin sequence. Foundational records identify KISS1 peptides as ligands of GPR54, now KISS1R.
Melanocortin fragment peptides
KPV
Lys-Pro-Val · alpha-MSH (11-13) · MSH (11-13)
KPV is a synthetic tripeptide, Lys-Pro-Val, corresponding to the C-terminal three residues of alpha-melanocyte-stimulating hormone.
Matrikine-derived peptides
KTTKS (Pentapeptide-4)
Pentapeptide-4 · Collagen pentapeptide
KTTKS is the unmodified pentapeptide from type I procollagen that forms the peptide backbone of the palmitoylated cosmetic ingredient Matrixyl.
GLP-1 receptor peptide analogs
Liraglutide
NN2211
Liraglutide is an acylated peptide analog of glucagon-like peptide-1, characterized against the GLP-1 receptor.
Growth hormone secretagogues
Macimorelin
AEZS-130 · JMV 1843 · EP-1572
Macimorelin is an orally active gem-diamino peptidomimetic agonist at the ghrelin receptor.
Multi-receptor incretin analogs
Mazdutide
IBI362 · IBI-362 · LY3305677 · LY-3305677 · IBI362 · LY3305677
Mazdutide is a lipidated synthetic peptide classified as a GLP-1 and glucagon receptor dual agonist, built on an oxyntomodulin-derived backbone.
Cyclic melanocortin analogs
Melanotan II
Melanotan-II · MT-II · MT-2
Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone, closed by a lactam bridge between an aspartate and a lysine side chain.
Mitochondrial-derived peptides
MOTS-c
Mitochondrial open reading frame of the 12S rRNA-c
MOTS-c is a sixteen-amino-acid peptide encoded by a short open reading frame within the mitochondrial 12S rRNA, rather than by the nuclear genome.
Nonpeptide receptor agonists
Orforglipron
LY3502970
Orforglipron is a synthetic nonpeptide molecule characterized as a selective, high-affinity agonist at the human GLP-1 receptor.
Incretin and glucagon receptor ligands
Oxyntomodulin
OXM · Glucagon-37
Oxyntomodulin is an endogenous proglucagon-derived peptide containing the complete glucagon sequence plus an eight-residue C-terminal extension, with reported activity at both the GLP-1 and glucagon receptors.
Neurotrophic peptide mimetics
P021 (P21)
P21 · P-21 · Peptide 021
P021 is a small acetylated tetrapeptide carrying an adamantane-derived C-terminal extension, designed as a CNTF-derived peptide mimetic.
Matrikine-derived peptides
Matrixyl
Pal-KTTKS · Palmitoyl-KTTKS · Palmitoyl pentapeptide-3
Palmitoyl pentapeptide-4 is the pentapeptide KTTKS with an N-terminal palmitoyl group, corresponding to a fragment sequence of type I procollagen.
Matrikine-derived peptides
Pal-GHK (Palmitoyl Tripeptide-1)
Pal-GHK · N-palmitoyl-GHK · C16-GHK · Palmitoyl oligopeptide
Pal-GHK is the N-palmitoylated derivative of the GHK tripeptide, used as a cosmetic ingredient and as an analytical internal standard.
Regulatory peptide fragment analogs
PE 22-28
PE(22-28) · Sortilin propeptide (22-28)
PE 22-28 is a synthetic heptapeptide corresponding to residues 22 to 28 of the sortilin propeptide. It is not a fragment of spexin; see the nomenclature note.
Growth hormone secretagogues
Pralmorelin (GHRP-2)
GHRP-2 · Growth hormone-releasing peptide-2 · KP-102
Pralmorelin is a synthetic hexapeptide growth hormone secretagogue acting at the ghrelin receptor, containing three D-configured residues and a naphthylalanine substitution.
Amylin and calcitonin receptor agonists
Pramlintide
AC137
Pramlintide is an engineered analog of human amylin carrying three proline substitutions, designed to address the aggregation behaviour of the native human sequence.
Copper-binding peptides · Matrikine-derived peptides
GHK (Prezatide)
GHK · Glycyl-L-histidyl-L-lysine · Tripeptide-1 · NSC-379527
GHK is the uncomplexed tripeptide ligand of the GHK-copper complex, identified in 1977 as a growth-modulating tripeptide from human plasma.
Copper-binding peptides · Matrikine-derived peptides
GHK-Cu
Copper tripeptide-1 · GHK copper · Cu-GHK
Prezatide copper is the Cu(II) coordination complex of the tripeptide glycyl-L-histidyl-L-lysine. The copper ion is part of the declared molecular identity and distinguishes this record from the free tripeptide.
Multi-receptor incretin analogs
Retatrutide
LY3437943
Retatrutide, development code LY3437943, is a single peptide characterized as an agonist at GCGR, GIPR, and GLP-1R in its discovery record.
Regulatory peptide fragment analogs
Selank
Selanc · Tuftsin-Pro-Gly-Pro
Selank is a synthetic heptapeptide consisting of the tetrapeptide tuftsin extended at the C-terminus with the tripeptide Pro-Gly-Pro.
GLP-1 receptor peptide analogs
Semaglutide
NN9535 · NNC 0113-0217
Semaglutide is an acylated peptide analog of glucagon-like peptide-1. Its discovery record identifies two amino-acid substitutions and derivatization at Lys26.
Regulatory peptide fragment analogs
Semax
ACTH(4-7)-Pro-Gly-Pro
Semax is a synthetic heptapeptide corresponding to residues 4 to 7 of adrenocorticotropic hormone extended at the C-terminus with the tripeptide Pro-Gly-Pro.
GHRH analogs
Sermorelin
GRF(1-29) · Sermorelina · Sermorelinum
Sermorelin is the synthetic peptide corresponding to residues 1 to 29 of human growth hormone-releasing factor, the unmodified parent fragment from which several longer-acting analogs are derived.
Cyclic melanocortin analogs · Melanocortin receptor ligands
Setmelanotide
RM-493 · BIM-22493 · IRC-022493
Setmelanotide is a synthetic disulfide-cyclized octapeptide characterised as an MC4R-preferring melanocortin receptor agonist.
Cyclic melanocortin analogs · Melanocortin receptor ligands
SHU9119
SHU-9119 · SHU 9119
SHU9119 is a cyclic lactam melanocortin analog whose receptor behaviour is subtype-dependent: antagonist at some melanocortin receptors and agonist at others.
Multi-receptor incretin analogs
Survodutide
BI 456906 · BI-456906 · BI 456906
Survodutide is a lipidated synthetic peptide agonist at both the GLP-1 receptor and the glucagon receptor, built on a modified glucagon-family backbone with a branched side-chain linker.
GHRH analogs
Tesamorelin
TH9507
Tesamorelin is a synthetic analog of human growth hormone-releasing factor, characterized in the literature as a GRF analog acting at the GHRH receptor.
Melanocortin receptor ligands
THIQ
THIQ is a nonpeptide small-molecule agonist at the melanocortin-4 receptor, included here as the nonpeptide comparator to the melanocortin peptides.
Thymosin-related peptides
Thymosin beta-4
Thymosin b4 · Tbeta4 · TB4
Thymosin beta-4 is an N-terminally acetylated peptide originally isolated from a thymic tissue fraction and subsequently characterized as a G-actin-sequestering peptide.
Multi-receptor incretin analogs
Tirzepatide
LY3298176
Tirzepatide is a fatty-acid-modified synthetic peptide characterized in its discovery record as having agonist activity at both the GIP receptor and the GLP-1 receptor.